Hudson Bay Capital Management LP
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1393825
STAMFORD, CT
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,000,000
-$668,312 QoQ
Shares Held
400,000
-18.4% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#71
of 316 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $72,604,865 across 10 Drug Manufacturers - Specialty & Generic names. BCRX ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHC |
Bausch Health Companies Inc.
|
5,000,000 | $24,650,000 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
130,000 | $21,910,200 | |
| 3 | GLAS |
Glass House Brands Inc.
|
750,000 | $9,750,000 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
275,000 | $4,408,250 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
400,000 | $4,000,000 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
5,000 | $2,709,150 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
70,009 | $2,427,211 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
234,000 | $973,440 |
All Filings in BCRX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,000,000 | 400,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,668,312 | 490,369 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,935,517 | 1,017,374 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $2,730,757 | 304,772 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $3,740,092 | 498,679 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 | $1,112,400 | 180,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,524,000 | 300,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $778,700 | 130,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $460,200 | 65,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $455,488 | 64,700 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $354,450 | 42,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $287,000 | 25,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||